Status:
UNKNOWN
Sphenopalatine Ganglion Blockade in Migraine
Lead Sponsor:
Afyonkarahisar Health Sciences University
Conditions:
Episodic Migraine
Eligibility:
All Genders
18-50 years
Phase:
PHASE3
Brief Summary
Migraine is a fairly common disease that is a leading cause of disability worldwide. 15% of the general population suffer from migraine headaches. Although there are currently many options for the tre...
Detailed Description
Between 1 May and 1 December 2021, 50 patients aged 18-50 years, who were diagnosed with episodic migraine according to ICD III criteria, who applied to the headache outpatient clinic of Afyonkarahisa...
Eligibility Criteria
Inclusion
- Having a diagnosis of episodic migraine (according to ICD-III)
- Receiving any prophylaxis treatment in the last 3 months,
Exclusion
- Being pregnant and lactating
- Neurological and psychiatric conditions (
- Contraindications to the use of local anesthetics
- Other chronic painful conditions,
- Having a history of malignancy
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05210192
Start Date
April 1 2022
End Date
January 1 2023
Last Update
January 27 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.